首页|期刊导航|现代中西医结合杂志|健脾利湿解毒方对脾虚湿毒型大肠腺瘤内镜术后患者预后的影响

健脾利湿解毒方对脾虚湿毒型大肠腺瘤内镜术后患者预后的影响OA

Effect of prescription for fortifying spleen,disinhibiting dampness and removing toxin on the prognosis of patients with colorectal adenomas with syndrome of spleen-deficiency and dampness-toxin after endoscopic surgery

中文摘要英文摘要

目的 观察健脾利湿解毒方对脾虚湿毒型大肠腺瘤内镜术后患者近远期疗效的影响.方法 将2021 年11 月—2023 年6 月在南京市中西医结合医院治疗的96 例脾虚湿毒型大肠腺瘤内镜术后患者随机分为2 组,对照组48 例给予健康宣教和生活饮食指导,治疗组48 例在对照组干预基础上给予健脾利湿解毒方治疗,2 组疗程均为3 个月.比较2 组治疗前及治疗 3 个月后中医证候积分、胃肠道生活质量指数(GIQLI)评分及血脂指标[三酰甘油(TG)、总胆固醇(TC)、高密度脂蛋白胆固醇(HDL-C)、低密度脂蛋白胆固醇(LDL-C)]水平,统计2 组不良反应发生情况及治疗后1 年腺瘤复发情况.结果 最终治疗组38 例、对照组42 例完成研究.治疗后治疗组主症积分、中医证候总积分及次症中气短懒言、身重肢倦、肠鸣、纳差、皮肤痤疮积分和血清 TG、TC、LDL-C 水平均明显低于治疗前及对照组(P 均<0.05),GIQLI 评分及血清 HDL-C 水平均明显高于治疗前及对照组(P 均<0.05);治疗后对照组主症积分、中医证候总积分及次症中气短懒言、身重肢倦积分均明显低于治疗前(P 均<0.05),GIQLI 评分明显高于治疗前(P<0.05).治疗组总有效率明显高于对照组[92.11%(35/38)比50.00%(21/42),P<0.05].2 组治疗期间未见明显不良反应.治疗后1 年,治疗组复发率明显低于对照组[28.95%(11/38)比54.76%(23/42),P<0.05],且复发腺瘤直径明显小于对照组(P<0.05),但 2 组复发腺瘤病理分型比较差异无统计学意义(P>0.05).结论 健脾利湿解毒方不仅可以改善脾虚湿毒型大肠腺瘤内镜术后患者的临床症状,提高患者的生活质量,且可调节脂质代谢,降低术后复发率.

Objective It is to evaluate the short-and long-term therapeutic effects of prescription for fortifying spleen,disinhibiting dampness and removing toxin in patients with colorectal adenomas with syndrome of spleen-deficiency and dampness-toxin after endoscopic surgery.Methods Ninety-six patients with colorectal adenomas with syndrome of spleen-deficiency and dampness-toxin after endoscopic surgery treated at Nanjing Hospital of Integrated Traditional and Western Medicine from November 2021 to June 2023 were randomly divided into2 groups.The control group(n=48)received health education and lifestyle/dietary guidance,while the treatment group(n=48)was treated with prescription for fortif-ying spleen,disinhibiting dampness and removing toxin based on the intervention in the control group,both groups were treated for 3 months.The TCM syndrome scores,Gastrointestinal Quality of Life Index(GIQLI)scores,and levels of blood lipid indicators[triglycerides(TG),total cholesterol(TC),high-density lipoprotein cholesterol(HDL-C),and low-den-sity lipoprotein cholesterol(LDL-C)]were compared between the two groups before treatment and 3 months after treat-ment,the incidence of adverse reactions and adenoma recurrence at 1 year after treatment were counted in both groups.Re-sults Thirty-eight patients in the treatment group and 42 in the control group finally completed the study.The scores of pri-mary symptoms,total TCM syndrome scores,and the scores of secondary symptoms such as shortness of breath and reluc-tance to speak,body heaviness and limb fatigue,borborygmi,poor appetite,and acne in the treatment group after treat-ment were all significantly lower,while the GIQLI scores and serum level of HDL-C were significantly higher than those be-fore treatment and in the control group after treatment(all P<0.05);the scores of primary symptoms,total TCM syn-drome scores,and the scores of secondary symptoms such as shortness breath and reluctance to speak,body heaviness and limb fatigue in the control group after treatment were all significantly lower,while the GIQLI scores were significantly higher than those before treatment(all P<0.05).The total effective rate in the treatment group was significantly higher than that in the control group[92.11%(35/38)vs50.00%(21/42),P<0.05].No significant adverse reactions were observed in either group during treatment.At one year after treatment,the recurrence rate in the treatment group was significantly lower than that in the control group[28.95%(11/38)vs 54.76%(23/42),P<0.05],and the diameter of recurrent adenomas was significantly smaller than that in the control group(P<0.05);however,there was no statistically significant difference in the pathological subtypes of recurrent adenomas between the two groups(P>0.05).Conclusion Prescription for fortifying spleen,disinhibiting dampness and removing toxin not only can improve clinical symptoms and enhances quali-ty of life,but also can regulate lipid metabolism and reduce the postoperative recurrence rate in the treatment of patients with colorectal adenomas with syndrome of spleen-deficiency and dampness-toxin after endoscopic surgery.

陈鑫;刘万里;吴昊

南京中医药大学附属南通市中医院,江苏 南通 226001南京医科大学附属南京医院(南京市第一医院),江苏 南京 210006南京中医药大学附属南京市中西医结合医院,江苏 南京 210014

医药卫生

大肠腺瘤健脾利湿解毒方复发脂质代谢

colorectal adenomaprescription for fortifying spleen,disinhibiting dampness and removing toxinrecur-rencelipid metabolism

《现代中西医结合杂志》 2026 (7)

913-918,6

江苏省中医药科技发展计划项目(YB2020030)

10.3969/j.issn.1008-8849.2026.07.006

评论